Nirat Beohar explains the financial landscape of the cath lab what is ahead

As cardiac catheterization laboratories take on more complex procedures and adopt rapidly evolving technologies, hospital leaders and interventional cardiologists are facing mounting financial pressures that threaten traditional care models. Nirat Beohar, MD, director of the cardiac catheterization laboratory and medical director of the structural heart disease program at Mount Sinai Medical Center in Miami Beach, outlined these challenges during a presentation at the TCT 2025, where he then spoke with Cardiovascular Business for a video interview.

“The cath lab is a very dynamic place in the hospital and it is also a big money-making part of the hospital,” Beohar said. “At the same time, the number of technologies that we offer to patients nowadays is rapidly increasing, which means that these procedures are getting more and more complex, more labor intensive, require more staffing, more imaging. And in that regard, also more costs.”

While procedural complexity and resource utilization have increased, Beohar noted that reimbursement has lagged behind. This creates what he described as an ongoing tension between delivering cutting-edge care and remaining financially solvent. Long, resource-intensive structural heart procedures raise questions about how to account for physician time, nursing and technologist staffing, imaging specialists and capital investments such as advanced imaging systems and image-fusion platforms.